DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,563,025 | -2.8% | 127,219 | -6.0% | 0.24% | +3.4% |
Q2 2023 | $32,485,379 | -5.9% | 135,356 | -1.2% | 0.23% | -11.5% |
Q1 2023 | $34,514,737 | -7.4% | 136,942 | -2.5% | 0.26% | -8.7% |
Q4 2022 | $37,268,684 | +2.2% | 140,414 | -0.6% | 0.29% | -4.3% |
Q3 2022 | $36,468,000 | +1.3% | 141,191 | -0.6% | 0.30% | +9.5% |
Q2 2022 | $36,006,000 | -14.4% | 142,026 | -1.0% | 0.27% | +0.4% |
Q1 2022 | $42,062,000 | -10.5% | 143,396 | +0.3% | 0.27% | -8.4% |
Q4 2021 | $47,017,000 | +7.8% | 142,905 | -0.3% | 0.30% | +1.4% |
Q3 2021 | $43,628,000 | +13.3% | 143,305 | -0.1% | 0.29% | +16.7% |
Q2 2021 | $38,490,000 | +17.6% | 143,425 | -1.4% | 0.25% | +14.0% |
Q1 2021 | $32,734,000 | +1.1% | 145,431 | -0.2% | 0.22% | -6.4% |
Q4 2020 | $32,367,000 | +1.1% | 145,703 | -2.0% | 0.24% | -14.2% |
Q3 2020 | $32,017,000 | +18.5% | 148,687 | -2.7% | 0.28% | +14.6% |
Q2 2020 | $27,026,000 | +29.6% | 152,837 | +1.4% | 0.24% | +7.1% |
Q1 2020 | $20,861,000 | -9.9% | 150,716 | -0.1% | 0.22% | +24.4% |
Q4 2019 | $23,160,000 | +6.6% | 150,899 | +0.3% | 0.18% | +0.6% |
Q3 2019 | $21,733,000 | -0.5% | 150,473 | -1.5% | 0.18% | -12.7% |
Q2 2019 | $21,841,000 | +16.3% | 152,823 | +7.4% | 0.20% | +10.8% |
Q1 2019 | $18,786,000 | +18.8% | 142,299 | -7.2% | 0.18% | +6.3% |
Q4 2018 | $15,818,000 | -5.6% | 153,397 | -0.5% | 0.17% | +14.5% |
Q3 2018 | $16,759,000 | +8.6% | 154,232 | -1.3% | 0.15% | +5.6% |
Q2 2018 | $15,426,000 | -0.5% | 156,323 | -1.3% | 0.14% | -4.6% |
Q1 2018 | $15,503,000 | +4.2% | 158,340 | -1.2% | 0.15% | +9.4% |
Q4 2017 | $14,877,000 | +7.8% | 160,273 | -0.4% | 0.14% | 0.0% |
Q3 2017 | $13,806,000 | +2.6% | 160,941 | +0.9% | 0.14% | -4.2% |
Q2 2017 | $13,455,000 | -2.1% | 159,442 | -0.7% | 0.14% | -2.0% |
Q1 2017 | $13,738,000 | +26.7% | 160,621 | +15.3% | 0.15% | +21.5% |
Q4 2016 | $10,846,000 | +0.0% | 139,339 | +0.7% | 0.12% | -6.9% |
Q3 2016 | $10,843,000 | -25.1% | 138,318 | -3.5% | 0.13% | -29.3% |
Q2 2016 | $14,470,000 | +6.2% | 143,263 | -0.2% | 0.18% | -2.1% |
Q1 2016 | $13,619,000 | -7.0% | 143,572 | -9.0% | 0.19% | -7.4% |
Q4 2015 | $14,649,000 | +2578.1% | 157,727 | +2356.8% | 0.20% | +2437.5% |
Q3 2015 | $547,000 | -95.9% | 6,420 | -95.9% | 0.01% | -95.5% |
Q2 2015 | $13,387,000 | +2146.1% | 156,408 | +2128.0% | 0.18% | +2137.5% |
Q1 2015 | $596,000 | -1.0% | 7,020 | -0.1% | 0.01% | -11.1% |
Q4 2014 | $602,000 | +46.1% | 7,024 | +29.5% | 0.01% | +50.0% |
Q3 2014 | $412,000 | -1.7% | 5,424 | +1.9% | 0.01% | 0.0% |
Q2 2014 | $419,000 | +12.9% | 5,324 | +7.7% | 0.01% | 0.0% |
Q1 2014 | $371,000 | -4.6% | 4,945 | -2.0% | 0.01% | 0.0% |
Q4 2013 | $389,000 | +32.3% | 5,045 | +18.8% | 0.01% | 0.0% |
Q3 2013 | $294,000 | – | 4,245 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |